IntellxxDNA

Diagnostic

Empowering clinicians with genomics-based insights to improve patient outcomes and personalize care.

Services
  • Clinical Decision Support Tool
  • Health Focused Genomic Reports
Location Austin, Texas
About

IntellxxDNA

In an era where precision is paramount, IntellxxDNA is revolutionizing the way physicians approach healthcare decisions. Unlike traditional genomics tools that focus solely on pharmacogenomics, cancer genomics, or rare diseases, IntellxxDNA provides a comprehensive solution for managing multifactorial chronic conditions such as heart disease, diabetes, cognitive decline, mental health issues, and autism, among others. By enabling physicians to identify and address the root causes of diseases, IntellxxDNA not only improves prevention and treatment but also reduces the cost of healthcare.

What sets IntellxxDNA apart is its ability to make genomics truly actionable. IntellxxDNA empowers physicians to implement personalized, precise treatment plans by reporting on gene variants with well-understood functions and pairing them with targeted potential interventions, including diet, lifestyle modifications, supplements and medications. This innovative approach is already being utilized by top physicians across the US to enhance patient outcomes and satisfaction and is being utilized in three IRB-approved trials focused on improving outcomes in cognitive decline and children with complex illness.

Unlock exclusive discounts and offers from IntellxxDNA and other trusted partners with an SSRP Pro Membership.
What People Say

Testimonials

I wanted to add my two cents worth in support of IntellxxDNA and Dr Sharon Hausman-Cohen MD, et al, as a Trusted Partner with SSRP. I have used different genetics companies in my practices since 2010, starting with Kendal Stewart, MD, working the actionable SNP’s to improve health in my patients care. Over the years I never really found a platform that provided relevant clinical guidance with all of the evidence backed research at your fingertips prior to engaging with Dr Hausman-Cohen and IntellxxDNA. I was so impressed I recommend this company to Dr Seeds as one of the missing pieces in the Cellular Medicine puzzle. Dr Seeds got back to me and expressed is thanks for introducing Dr Hausman-Cohen. He said that she was the first doctor that could answer all his questions and provide a workable clinical platform to make the complex useful and improve the clinical success that SSRP Members are looking for. I have attended their monthly case studies, worked with their trainers on my complex patients and can say their support is excellent, the guidance is clinically valuable and adding IntellxxDNA to the Trusted Partners will be a valuable benefit for our Membership.

Kenton Crowley, Pharm.D., ABAAHP, FAARFM, CEO, President Palliative Care Consultants, LLC.; Crowley Consultants, Inc.
Network with our partners

Upcoming Events

View Upcoming Events
EVENT
Grand Rounds
December 4 - 5, 2026

Grand Rounds

Coming Soon
RESOURCES

Join us in breaking down the latest research live.

VIEW ALL
PODCAST
Redox Revolution
Oct 13, 2026
Ep.81 – The Crossover Between Cellular Medicine and Regenerative Aesthetics with Angel Channell
Ep.81 – The Crossover Between Cellular Medicine and Regenerative Aesthetics with Angel Channell

In this episode of Redox Revolution, Dr. Seeds sits down with aesthetician Angela Channel to discuss her approach not only to skin care but overall holistic healing.

Cellular Medicine Foundations
VIDEO
Cellular Medicine Mondays
Oct 12, 2026
Ep. 109 - Anti-Ageing Mini Mastermind Part 2
Preview only
Journal Club – Episode 109

Anti-Aging Mini Mastermind Part 2

In Part 2 of our Anti-Aging Mini Mastermind series, Dr. Seeds explores how PGE2 signaling and cellular metabolism influence inflammation, cognitive function, and aging, connecting foundational research to emerging discoveries in immunometabolism.  (2026 Article) (2021 Article)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
William Seeds, MD Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
Revisiting a Journal Club Article, “Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.” Science. 2026  Why This Paper Matters Most of the senescence conversation over the past decade has centered on a familiar cast: senescent fibroblasts, endothelial cells, adipocytes, and the drugs designed to clear them. This paper, which I discuss in […]
READ ARTICLE
Healthgevity Oct 2, 2026
Healthgevity Introduces hydraCELL+â„¢, Featuring Formulation IP Developed by the Seeds Foundation for Cellular Research
BREAKING NEWS INTERLAKEN, N.J., [October 2, 2026] — Healthgevity, a practitioner-focused precision longevity nutrition company, announced the launch of hydraCELL+â„¢, a cellular hydration and muscle-support formula built on proprietary formulation IP developed through the Seeds Foundation for Cellular Research and licensed to Healthgevity. The formula reflects the cellular medicine approach advanced by William Seeds, MD, and […]
READ NEWS
ARTICLE
William Seeds, MD
Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
William Seeds, MD Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
Why a Plucked Hair Follicle May Matter to the Future of Regenerative Medicine In this article, I return to a study that I discussed in a July Journal Club post. The study, published in Cells in 2024, investigated whether cells obtained from plucked, cryopreserved human hair follicles could be reprogrammed into induced pluripotent stem cells […]
READ ARTICLE
Peptide Therapy Certification 2026
The SSRP Peptide Therapy Certification course gives clinicians, researchers, and other healthcare providers a working method for applying Cellular Medicine principles to patient care through clinical peptide therapy. Across 19 faculty-led lessons, Dr. William Seeds and SSRP faculty, including Siobhan...
19 Lessons
15 hrs 43 min
View Course
SSRP Institute Sep 14, 2026
In Case You Missed it: FDA Approves Mounjaro (tirzepatide) for CVD
HEADLINE SCIENCE [Sept 14, 2026] – On August 28, 2026, the FDA expanded the indication for Mounjaro (tirzepatide), approving the dual GIP/GLP-1 receptor agonist to reduce the risk of major adverse cardiovascular events—including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke—in adults with type 2 diabetes at high cardiovascular risk. The decision makes tirzepatide the […]
READ NEWS
EVENT
Certification
September 10 - 11, 2027
Peptide Therapy Certification 2027
Four Seasons Resort Orlando at Walt Disney World, FL
COMING SOON
Certification
Peptide Therapy Certification 2027
COMING SOON
EVENT
World Congress
June 17 - 19, 2027
Peptide World Congress 2027
Arizona Biltmore, Phoenix, AZ
COMING SOON
World Congress
Peptide World Congress 2027
COMING SOON
EVENT
Mastermind
February 15 - 19, 2027
Fellowship Mastermind Summit 2027
Gansevoort Meatpacking NYC, New York, NY
COMING SOON
Mastermind
Fellowship Mastermind Summit 2027
COMING SOON
EVENT
Grand Rounds
December 4 - 5, 2026
Grand Rounds
Four Seasons Resort and Residences Vail
COMING SOON
Grand Rounds
Grand Rounds
COMING SOON
SSRP Institute Aug 27, 2026
Rasonque: An FDA-Approved Drug to Treat Pancreatic Cancer
HEADLINE SCIENCE [August 27, 2026] – The Food and Drug Administration on Wednesday approved daraxonrasib, sold as Rasonque, for adults with metastatic pancreatic adenocarcinoma, the most common form of pancreatic cancer and one long considered among the hardest to treat. The once-daily tablet, developed by Revolution Medicines, is the first targeted therapy approved for the […]
READ NEWS